Biotech IDEAYA Biosciences Announces Clinical Collaboration with Genentech in MTAP-Deleted KRAS G12D-Mutant Pancreatic Cancer August 19, 2026
Biotech Invitation to presentation of BioArctic’s second quarter report for April – June 2026 on August 26 at 9:30 a.m. CEST August 19, 2026
Biotech Psyence BioMed Welcomes U.S. Administration’s Latest Action to Accelerate Ibogaine Development August 19, 2026
Biotech Hansa Biopharma announces first commercial kidney transplant patient treated with Idefirix in Australia August 18, 2026
Biotech Coherus Oncology Announces Special Dividend of Biosimilar Contingent Value Rights August 18, 2026
Biotech HUTCHMED Announces ORPATHYS® Plus TAGRISSO® Demonstrated Statistically Significant and Clinically Meaningful Improvements in Progression-Free and Overall Survival in MET-Driven EGFR-Mutated Lung Cancer After Progression on TAGRISSO® August 17, 2026
Biotech Mesoblast Achieves Major Milestone Completing Patient Treatment in Pivotal Phase 3 Trial for Chronic Low Back Pain August 17, 2026
Biotech argenx Announces Positive Topline Results from Phase 3 ALKIVIA Trial of Efgartigimod in Autoimmune Myositis August 17, 2026